Loading...

International Business

Global Presence

After leaving footprints in Indian market for 4 decades, Unison is now foraying into International Business with strong foundation laid on two state-of-the-art manufacturing facilities include one EU-GMP approved facility. Products are manufactured with stringent quality standard and regulatory norms to match the requirement of the respective international markets. The product range encompasses various therapeutic segment like Cardio, Diabetes, Pain management, Anti Allergic, Anti-Fungal etc. We have already entered into strategic tie-ups and alliances in different countries across the globe which will help us in widening our reach internationally.

  • Australia
  • Belgium
  • Canada
  • Denmark
  • Finland
  • France
  • Iceland
  • Luxembourg
  • Netherlands
  • Libya
  • New Zealand
  • Norway
  • Spain
  • Sweden
  • United Kingdom
  • Kenya
  • Nigeria
  • Uganda
  • Sudan
  • Qatar
  • Rwanda
  • Tanzania
  • Benin
  • Malaysia
  • Philippines
  • Vietnam
  • Singapore
  • Myanmar
  • Brunei
  • Colombia
  • Afghanistan
  • Uzbekistan
  • Bolivia
  • DR
  • Ecuador
  • Nicaragua
  • El Salvador
  • Honduras
  • Guatemala
  • Costa Rica
  • Panama
  • Belize
  • Peru
  • Chile
  • Jamaica
  • Haiti
  • Yemen

The Company has strong Quality Management System in place which helps in delivering unmatched quality products batch after batch which has won the trust of medical fraternity who rely on our products to treat their patient.

The Company has its own R&D Centre. which is recognized by Department of Science & Technology, Government of India. This helps in developing the strong product portfolio and pipeline of newer molecules for various markets across the globe.

Collaborate with us

Collaborate with us

The Company is looking for partners across all geographies.

Interested company can contact us on : international@unisonpharmaceuticals.com

reserch devlopment

Research & Development

An independent R&D center recognized by the DSIR (Government of India), has been the originator of process technology platforms for our existing and pipeline products. Our primary focus is to provide quality medicines with better patient compliance by providing novel drug delivery systems.